157 related articles for article (PubMed ID: 25860379)
1. Controversial evidence for the use of HistoScanning™ in the detection of prostate cancer.
Schiffmann J; Manka L; Boehm K; Leyh-Bannurah SR; Karakiewicz PI; Graefen M; Hammerer P; Salomon G
World J Urol; 2015 Dec; 33(12):1993-9. PubMed ID: 25860379
[TBL] [Abstract][Full Text] [Related]
2. True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical efforts.
Schiffmann J; Mehring G; Tennstedt P; Manka L; Boehm K; Leyh-Bannurah SR; Karakiewicz PI; Hammerer P; Graefen M; Salomon G
World J Urol; 2016 Apr; 34(4):495-500. PubMed ID: 26215749
[TBL] [Abstract][Full Text] [Related]
3. HistoScanning
Wysock JS; Xu A; Orczyk C; Taneja SS
Curr Urol Rep; 2017 Oct; 18(12):97. PubMed ID: 29064054
[TBL] [Abstract][Full Text] [Related]
4. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies.
Javed S; Chadwick E; Edwards AA; Beveridge S; Laing R; Bott S; Eden C; Langley S
BJU Int; 2014 Oct; 114(4):541-8. PubMed ID: 24224648
[TBL] [Abstract][Full Text] [Related]
5. Application of ultrasound imaging biomarkers (HistoScanning™) improves staging reliability of prostate biopsies.
Hamann MF; Meyer D; Knüpfer S; Fuchs J; Jünemann KP; Naumann CM
BMC Res Notes; 2017 Nov; 10(1):579. PubMed ID: 29121982
[TBL] [Abstract][Full Text] [Related]
6. Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?
Hamann MF; Hamann C; Trettel A; Jünemann KP; Naumann CM
BMC Urol; 2015 Jul; 15():76. PubMed ID: 26223353
[TBL] [Abstract][Full Text] [Related]
7. Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate.
Schiffmann J; Tennstedt P; Fischer J; Tian Z; Beyer B; Boehm K; Sun M; Gandaglia G; Michl U; Graefen M; Salomon G
World J Urol; 2014 Aug; 32(4):925-30. PubMed ID: 24871425
[TBL] [Abstract][Full Text] [Related]
8. Sextant-Specific Analysis of Detection and Tumor Volume by HistoScanning™.
Porres D; Kuru TH; Epplen R; Eck A; Zugor V; Kennes LN; Afram S; Braunschweig T; Knüchel-Clarke R; Pfister D; Heidenreich A
Urol Int; 2016; 96(2):194-201. PubMed ID: 26555799
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological results.
Schiffmann J; Fischer J; Tennstedt P; Beyer B; Böhm K; Michl U; Graefen M; Salomon G
World J Urol; 2014 Aug; 32(4):939-44. PubMed ID: 24270968
[TBL] [Abstract][Full Text] [Related]
10. [Value of perineal HistoScanning™ template-guided prostate biopsy].
Hamann MF; Hamann C; Olzem D; Trettel A; Juenemann KP; Naumann CM
Urologe A; 2015 Nov; 54(11):1596, 1598-601. PubMed ID: 25794587
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of Histoscanning™ in prostate cancer diagnostics.
Morozov A; Kozlov V; Rivas JG; Teoh JY; Bezrukov E; Amosov A; Barret E; Taratkin M; Salomon G; Herrmann TRW; Gozen A; Enikeev D;
World J Urol; 2021 Oct; 39(10):3733-3740. PubMed ID: 33825986
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
13. [Preoperative endorectal MRI in prostate cancer: a monocentric retrospective cohort].
de Vendin C; Eydant Y; Ecochard R; Lorin S; Lacroix B; Lardon R; Mottet N
Prog Urol; 2013 Dec; 23(16):1412-8. PubMed ID: 24274946
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
15. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
16. Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™).
Simmons LA; Autier P; Zát'ura F; Braeckman J; Peltier A; Romic I; Stenzl A; Treurnicht K; Walker T; Nir D; Moore CM; Emberton M
BJU Int; 2012 Jul; 110(1):28-35. PubMed ID: 22093966
[TBL] [Abstract][Full Text] [Related]
17. Utility of Histoscanning™ prior to prostate biopsy for the diagnosis of prostate adenocarcinoma.
Núñez-Mora C; García-Mediero JM; Patiño P; Orellana C; Garrido A; Rojo A; Rendón D
Actas Urol Esp; 2013 Jun; 37(6):342-6. PubMed ID: 23507291
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive report on prostate cancer misclassification by 16 currently used low-risk and active surveillance criteria.
Palisaar JR; Noldus J; Löppenberg B; von Bodman C; Sommerer F; Eggert T
BJU Int; 2012 Sep; 110(6 Pt B):E172-81. PubMed ID: 22314081
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
Epstein JI
J Urol; 2011 Sep; 186(3):790-7. PubMed ID: 21788055
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer polar localization on core biopsy predicts pathologic stage.
Hensley PJ; Bailey LR; Purdom MS; Davenport DL; Strup SE
Can J Urol; 2016 Dec; 23(6):8551-8556. PubMed ID: 27995850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
